MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauro, D. J.
Right arrow Articles by Sirover, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauro, D. J.
Right arrow Articles by Sirover, M. A.

Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells

DJ Mauro, JK De Riel, RJ Tallarida and MA Sirover

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

Recent evidence indicates that 5-fluorouracil (5-FlUra) is incorporated into DNA and is removed by the DNA repair enzyme uracil DNA glycosylase. Synthetic oligonucleotides containing either a single uracil or 5-FlUra residue were constructed to examine the mechanisms by which human cells remove 5-FlUra from DNA. The human uracil DNA glycosylase excised uracil in a manner similar to that observed for the bacterial enzyme. In contrast, a significant difference was observed in their abilities to remove 5-FlUra. In particular, both the bacterial and normal human enzymes displayed 13-17-fold increases in their apparent Km values but the apparent Vmax values remained virtually constant. These results demonstrate that normal human cells possess a defined capacity to remove 5-FlUra incorporated into DNA. However, specific kinetic differences may exist that affect their capacity to remove 5-FlUra formed in DNA after treatment with this cancer chemotherapeutic agent.

Volume 43, Issue 6, pp. 854-857, 06/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. T. Morgan, M. T. Bennett, and A. C. Drohat
Excision of 5-Halogenated Uracils by Human Thymine DNA Glycosylase: ROBUST ACTIVITY FOR DNA CONTEXTS OTHER THAN CpG
J. Biol. Chem., September 21, 2007; 282(38): 27578 - 27586.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. An, P. Robins, T. Lindahl, and D. E. Barnes
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
Cancer Res., February 1, 2007; 67(3): 940 - 945.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Andersen, T. Heine, R. Sneve, I. Konig, H. E. Krokan, B. Epe, and H. Nilsen
Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts
Carcinogenesis, March 1, 2005; 26(3): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
P. Noordhuis, U. Holwerda, C. L. Van der Wilt, C. J. Van Groeningen, K. Smid, S. Meijer, H. M. Pinedo, and G. J. Peters
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
Ann. Onc., July 1, 2004; 15(7): 1025 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-B. Lin, P. O. P. Ts'o, S.-K. Sun, K.-B. Choo, F.-Y. Yang, Y.-P. Lim, H.-L. Tsai, and L.-C. Au
Inhibition of Thymidylate Synthase Activity by Antisense Oligodeoxynucleotide and Possible Role in Thymineless Treatment
Mol. Pharmacol., September 1, 2001; 60(3): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. E. Farez-Vidal, C. Gallego, L. M. Ruiz-Perez, and D. Gonzalez-Pacanowska
Characterization of uracil-DNA glycosylase activity from Trypanosoma cruzi and its stimulation by AP endonuclease
Nucleic Acids Res., April 1, 2001; 29(7): 1549 - 1555.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A.-S.A. Ismail, C. J. Van Groeningen, A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem.
Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma
Mol. Pharmacol., February 1, 1998; 53(2): 252 - 261.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics